What we're reading, March 10, 2016: spending on drug advertisements up 60% over 4 years; lawsuit between Gilead and Merck over hepatitis C virus drugs; and Tennessee considers allowing pharmacists to prescribe contraceptives.
Despite lawmakers pushing for tighter restrictions on drug advertisements, drug makers are pouring more money into TV and print campaigns. STAT reported that ad spending increased 60% in the last 4 years and 9 prescription drugs are expected to spend more than $100 million for ad time. Humira, Lyrica, Eliquis, Cialis, and Xeljanz were responsible for the most ad spend last year.
A lawsuit between Gilead Sciences and Merck & Co will kick off this week regarding patent claims on Gilead’s hepatitis C virus drugs. Merck wants a cut of Gilead’s sales of Sovaldi and Harvoni because the active ingredient, sofosbuvir, infringes 2 of Merck’s patents, reported The Wall Street Journal. Gilead is seeking a judgement that Merck’s patents are invalid. Gilead is also having trouble with AbbVie, which also claims Gilead’s drugs infringe patents covering various drug combinations.
Tennessee could become the next state to allow women to obtain contraceptives from a pharmacist. The bill, which would allow pharmacists who enter an agreement with a physician and meets certain provisions to prescribe birth control, passed the state Senate, reported USA Today. Since the pharmacist would still need to write a prescription, health insurance would cover the cost. This Tennessee bill follows similar ones passed in Oregon and California.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More